Standard Biotools (LAB) Return on Invested Capital Growth (1y) (2012 - 2025)
Standard Biotools (LAB) Return on Invested Capital Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | -1.00 |
| 2 | Stryker | 132.13 Bn | 129.26 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 111.43 Bn | 102.21 Bn | 6.41 Bn | 0.00 |
| 4 | Boston Scientific | 68.97 Bn | 67.52 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.64 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.91 Bn | 27.79 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.86 Bn | 26.58 Bn | 1.98 Bn | 0.00 |
| 8 | Smith & Nephew | 28.12 Bn | 27.54 Bn | - | - |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | 0.00 |
| 10 | Standard Biotools | 302.22 Mn | -152.96 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 5.00 |
| Dec 31, 2024 | 2.00 |
| Sep 30, 2024 | 4.00 |
| Jun 30, 2024 | 7.00 |
| Mar 31, 2024 | 17.00 |
| Dec 31, 2023 | 48.00 |
| Jun 30, 2013 | -5.00 |
| Mar 31, 2013 | -2.00 |
| Dec 31, 2012 | -1.00 |
| Sep 30, 2012 | 0.00 |
| Jun 30, 2012 | 1.00 |